ICU Medical Inc (ICUI) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.

Total Assets Chart for ICU Medical Inc

ICU Medical Inc (ICUI) total assets for FY2025 were USD 4.1B, a -3.6% change from FY2024. ICU Medical Inc's total assets grew from USD 4.3M in 1991 to USD 4.1B in 2025 (94097.9% over 34 years). Total assets compound annual growth rate: 5-year CAGR of 18.1%, 10-year CAGR of 20.5%, 20-year CAGR of 16.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.08B
Implied Share Price
$162.99
Enterprise Value
$5.00B
Revenue (TTM)
$2.16B
EBITDA
$326.12M
Profit Margin
1.39%
Trailing P/E
136.97
Forward P/E
16.95
Price/Book (MRQ)
1.87
Price/Sales (TTM)
1.89
EV/EBITDA
17.59
EV/Revenue
2.31
Dividend Yield
—
Book Value
$86.05
Free Cash Flow (FY2025)
$91.80M
Free Cash Flow Yield
2.25%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.